StockData
Lumexa Imaging Holdings, Inc. logo

Lumexa Imaging Holdings, Inc. (LMRI) stock

LMRINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$14.01−0.62 (-4.24%)

Close on Nov 18, 2026Market cap $1.35BP/E –Yield –

Earnings

Lumexa Imaging's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 25, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$272.00M
Adjusted EPS, Q3 FY2026
$0.26
Latest guidance
Raised
Nov 10, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Lumexa Imaging's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Mar 25, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 10, 2026after the close$272.00M–$0.07$0.26Release
Q2 FY2026ended Jun 30, 2026Aug 12, 2026during market hours$264.20M–$0.03$0.20Release
Q1 FY2026ended Mar 31, 2026May 12, 2026during market hours$252.50M–$0.02$0.18Release
Q4 FY2025ended Dec 31, 2025Mar 26, 2026before the open$267.70M–-$0.38–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Lumexa Imaging's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
consolidated revenueGAAPFY2026$1.05B – $1.10B$1.05B – $1.10BReaffirmedNov 10, 2026
consolidated revenueFY2026$1.05B – $1.10B$1.05B – $1.10BReaffirmedAug 12, 2026
Adjusted EBITDAnon-GAAPFY2026$236.00M – $240.00M$234.00M – $242.00MNarrowedNov 10, 2026
Adjusted EBITDAnon-GAAPFY2026$235.00M – $241.00M$234.00M – $242.00MNarrowedAug 12, 2026
Adjusted EPSnon-GAAPFY2026$0.86 – $0.90$0.71 – $0.77RaisedNov 10, 2026
Adjusted EPSnon-GAAPFY2026$0.71 – $0.77$0.71 – $0.77ReaffirmedAug 12, 2026

Guidance history

Every forecast Lumexa Imaging put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 10, 2026Adjusted EBITDAFY2026$236.00M – $240.00MNarrowed
Nov 10, 2026Adjusted EPSFY2026$0.86 – $0.90Raised
Nov 10, 2026consolidated revenueFY2026$1.05B – $1.10BReaffirmed
Aug 12, 2026Adjusted EBITDAFY2026$235.00M – $241.00MNarrowed
Aug 12, 2026Adjusted EPSFY2026$0.71 – $0.77Reaffirmed
Aug 12, 2026consolidated revenueFY2026$1.05B – $1.10BReaffirmed
May 12, 2026Adjusted EBITDAFY2026$234.00M – $242.00MReaffirmed
May 12, 2026Adjusted EPSFY2026$0.71 – $0.77New
May 12, 2026Consolidated revenuesFY2026$1.05B – $1.10BReaffirmed
Mar 26, 2026Adjusted EBITDAFY2026$234.00M – $242.00MNew
Mar 26, 2026Adjusted EPSFY2026$0.71 – $0.77New
Mar 26, 2026Consolidated revenuesFY2026$1.05B – $1.10BNew
Mar 2, 2026Adjusted EBITDAFY2026$234.00M – $242.00MNew
Mar 2, 2026Consolidated revenuesFY2026$1.05B – $1.10BNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Lumexa Imaging filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?